Abstract:BACKGROUND: Of the many growth factors that can enhance bone formation, the bone morphogenic proteins (BMPs) are probably the most effective and most widely studied for applications requiring new bone growth. To analyze the effects, the gold standard is patient randomized control trials, however, only BMP-2 and BMP-7 have reached this level of investigation. OBJECTIVE: In this meta analysis the recent findings concerning the application of recombinant human bone morphogenic protein-2 (rhBMP-2) in tissue engineering and gene therapy, the options of its transfer means, as well as the ideal time of delivery is discussed. RETRIEVAL STRATEGY: The relevant articles published between January 1997 and December 2006 were searched for in Pubmed database by researcher of this article with the key words "recombinant human bone morphogenic proteins (rhBMPs), tissue engineering, gene therapy" in English. A total of 81 articles were selected and reviewed by the standards of: ① Having close relations with the application of rhBMP-2 in tissue engineering and gene therapy; ② The most recently published articles and articles in authority journals were chosen in the same field. Exclusion criteria: repetitive studies. LITERATURE EVALUATION: The main sources of literature are the application of rhBMP-2 in tissue engineering and gene therapy. Among the 52 selected articles, 12 are reviews or meeting reports, others are clinical or elementary experimental studies. DATA SYNTHESIS: BMPs are members of the TGF-β superfamily, which are released by osteoprogenitor cells and typically improve bone growth. The use of scaffolds, cells, and growth factors for bone regeneration is called bone tissue engineering. The application of rhBMP-2 in tissue engineering holds great promise for the augmentation and manipulation of bone and soft tissue repair. One potential alternative to direct rhBMP-2 delivery is to develop a biologic cellular delivery vehicle via gene therapy to enhance bone formation. The application of rhBMP-2 in gene therapy holds great promise for the augmentation and manipulation of bone and soft tissue repair. The research indicated that the dosing, time, and transfer mode of rhBMP-2 to the desired targets remain a facing challenge. Further studies should focus on the ideal dosing, time and method of delivery, which should be easily and reliably displayed, cost effective, and clearly controlled. CONCLUSION: The future of bone and soft tissue repair will likely be based on biologic augmentation of healing and tissue regeneration. The use of rhBMP-2 holds great promise for the augmentation and manipulation in tissue engineering and gene therapy.

Regulating the Bioactivity of Non-Glycosylated Recombinant Human Bone Morphogenetic Protein-2 to Enhance Bone Regeneration

Studies on Recombinant Human Bone Morphogenetic Protein 2 Loaded Nano-Hydroxyapatite/Silk Fibroin Scaffolds

Expression, Purification, and Refolding of a Recombinant Human Bone Morphogenetic Protein 2 in Vitro

Biomaterial-guided Immobilization and Osteoactivity of Bone Morphogenetic Protein-2

Recombinant human bone morphogenic protein-2 in tissue engineering and gene therapy

Refolding and two-step purification by hydrophobic interaction chromatography of recombinant human bone morphogenetic protein-2 from Escherichia coli

Calcium ion-induced formation of β-sheet/-turn structure leading to alteration of osteogenic activity of bone morphogenetic protein-2

Tuning the Bioactivity of Bone Morphogenetic Protein-2 with Surface Immobilization Strategies

The Evaluation of Bioactivity of the Recombinant Human Bone Morphogenetic Protein - 2

Dose Reduction of Bone Morphogenetic Protein-2 for Bone Regeneration Using a Delivery System Based on Lyophilization with Trehalose.

The Regulatory Role of Sulfated Polysaccharides in Facilitating Rhbmp-2-induced Osteogenesis

Localization and Promotion of Recombinant Human Bone Morphogenetic Protein-2 Bioactivity on Extracellular Matrix Mimetic Chondroitin Sulfate-Functionalized Calcium Phosphate Cement Scaffolds.

Optimized Procedure for Expression and Renaturation of Recombinant Human Bone Morphogenetic Protein-2 at High Protein Concentrations

Effect of recombinant human bone morphogenetic protein-2 sustained release microspheres on the proliferation and differentiation of osteoblasts

Preparation of Recombinant Human Bone Morphogenetic Protein-2 Loaded Dextran-Based Microspheres and Their Characteristics

[In Vitro Osteogenesis of the Compound of Chitosan and Recombinant Human Bone Morphogenetic Protein 2].

Novel Strategies for Spatiotemporal and Controlled BMP-2 Delivery in Bone Tissue Engineering

Enhancement of bone formation by recombinant human bone morphogenetic protein-2/chitosan bone biomaterials

In vitro sustained release of recombinant human bone morphogenetic protein-2 microspheres embedded in thermosensitive hydrogels

Refolding and Purification of rhBMP-2 Expressed as Inclusion Bodies in E.COLI with Hydroxyapatite Chromatography

Efficient Delivery of Recombinant Human Bone Morphogenetic Protein (Rhbmp-2) with Dextran Sulfate-Chitosan Microspheres